Eratos Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Eratos Therapeutics General Information

Description

Developer of artificial intelligence-based brain mapping technology designed for identifying therapeutic targets for neurological drug research. The company's platform generates predictive nanoscale maps of brain biology to analyze cellular and molecular interactions, enabling pharmaceutical and biotechnology researchers to identify targets for central nervous system drug discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 445 Ramona Road
  • Portola Valley, CA 94028
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 445 Ramona Road
  • Portola Valley, CA 94028
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eratos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 09-Feb-2026 Completed Startup
To view Eratos Therapeutics’s complete valuation and funding history, request access »

Eratos Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
One Mind Accelerator/Incubator
To view Eratos Therapeutics’s complete investors history, request access »

Eratos Therapeutics FAQs

  • When was Eratos Therapeutics founded?

    Eratos Therapeutics was founded in 2025.

  • Where is Eratos Therapeutics headquartered?

    Eratos Therapeutics is headquartered in Portola Valley, CA.

  • What industry is Eratos Therapeutics in?

    Eratos Therapeutics’s primary industry is Drug Discovery.

  • Is Eratos Therapeutics a private or public company?

    Eratos Therapeutics is a Private company.

  • What is Eratos Therapeutics’s current revenue?

    The current revenue for Eratos Therapeutics is .

  • Who are Eratos Therapeutics’s investors?

    One Mind has invested in Eratos Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process